NYR
NYRADA INC.
$0.4800
▼ -7.69%
Market cap
$119M
Turnover
$668,469
Last price
$0.4800
Day change
-7.69%
Announcements
14
Range, past year
Open 0.300 · Low 0.095 · Now 0.480 · High 1.435
Open NYR in the full dashboard →
Charts, screener, momentum and signals across every ASX-listed code.
NYR momentum and trend analysis
Our analysis
Independent analysis generated by Stock Trade Intelligence
as at 2026-09-28.
Momentum quality
28/100
Wyckoff phase
Downtrend6d
Trend stage
Breakdown
1 Day
-7.7%
1 Week
-22.6%
1 Month
-42.2%
1 Year
+68.4%
RSI
30
Avg daily range
11.1%
NYRADA INC. scores 28 out of 100 for momentum quality, a reading rated very low confidence. The score weighs trend structure, price consistency, volume backing and how long the move has held, so a high reading means a sustained trend rather than a single large day. Its trend is currently classified as Breakdown.
On the Wyckoff cycle it sits in Downtrend, where it has been for 6 trading days. The weekly timeframe reads Accumulation, which does not yet agree with the daily view.
Against the wider market it is currently underperforming and the institutional accumulation signal reads low.
Points to watch
- RSI oversold (30)
- 60d drawdown -42.2%
- High volatility (ATR 11.1%)
- Risk rating: Very High
- Composite downside risk elevated
Browse the whole market by signal:
ASX stocks in Wyckoff accumulationASX momentum stocks by trend qualityASX stocks breaking outASX stocks near 52-week highsNYR announcements
Recent price-sensitive releases.
- 2026-09-21 Nyrada Successfully Raises AU$12.0 Million Via Placement Placement | Trading Halt Lifted | Security Purchase Plan
- 2026-09-21 Cap Raise Deck-Building the Future of TRPC-based Therapies Company Presentation | Placement | Security Purchase Plan
- 2026-09-17 Trading Halt Trading Halt
- 2026-08-21 Xolatryp Demonstrates Cardioprotection in Preclinical Study Progress Report
- 2026-08-18 Preliminary Final Report Preliminary Final Report
- 2026-07-27 Quarterly Activities Report and Appendix 4C Commitments Test Entity - Fourth Quarter Activity Report | Commitments Test Entity - Fourth Quarter Cashflow Report
- 2026-07-15 Response to ASX Price Query
More Health Care stocks
Most traded in the same sector.